Biktarvy, formally known as bictegravir sulfate, is a potent single-tablet treatment for managing HIV infection. This drug unites three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the the viral ability to copy within the body, considerably decreasing the viral quantity. For many individual